2008 Press Releases
Dec 26, 2008Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
Dec 26, 2008Allergan Announces U.S. Food and Drug Administration (FDA) Approval of LATISSE™ -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
Dec 5, 2008FDA Advisory Committee Unanimously Recommends Approval of LATISSE(TM) (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes
Oct 29, 2008 Oct 29, 2008Allergan, Inc. and Spectrum Pharmaceuticals, Inc. Announce Collaboration Agreement for Apaziquone (EOquin(R)
Oct 15, 2008Allergan, Inc. and Clinique Announce Nationwide Availability of CLINIQUE MEDICAL
Oct 3, 2008 Sep 11, 2008Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache Program
Jul 30, 2008 Jul 18, 2008Validity of Allergan Patents Acknowledged by Jan Marini in Settlement of Allergan's Patent Infringement Suit Against Jan Marini Skin Research, Inc.
Jul 15, 2008Legendary Sports Icons, Nadia Comaneci and Mark Spitz, Support Your Personal Best Public Education Campaign
Jul 14, 2008 Jul 8, 2008 Jun 16, 2008Allergan Receives U.S. Food and Drug Administration Approval for TRIVARIS™ (triamcinolone acetonide injectable suspension) 80 mg/mL
Jun 9, 2008 Jun 4, 2008Allergan Announces Intent to File New Drug Application for Bimatoprost as Novel Treatment to Stimulate Natural Eyelash Growth
May 7, 2008 May 1, 2008 Apr 8, 2008 Mar 3, 2008Allergan Comments on the United States Department of Justice Subpoena for the Production of Documents Relating to Promotional Practices of BOTOX(R) for Therapeutic Uses
| Showing 1-20 of 27 |
| Page: 1 2 |
| Next 20 |